Following the starting point presented here, subsequent comprehensive analyses of RON function in pediatric sarcomas should include alternative shRNA sequences or transgenic rescue control and the design of such future RNA interference or CRISPR sequences should account for the predominant isoforms at play. Here, MST1R is linked to sarcoma.